To the Editor: We read with interest the article by Demant et al [1], which reported that severity of heart failure was associated with a graduated risk of new-onset diabetes. Demant et al underscored the importance of focusing on the underlying concomitant disease and its effect on future outcomes in patients with heart failure.
However, we think that it is premature to draw a conclusion on the cause-and-effect relationship between severity of heart failure and incident diabetes. In fact, the observation in the study can be explained by reverse causality: pre-existing metabolic disturbance resulting in a higher dosage of loop diuretics. Most of the risk factors for diabetes, e.g. race, weight, physical activity, dietary quality, smoking [2], were not presented in the article. As the renin–angiotensin system and sympathetic system activation are involved in obesity [3, 4], impaired glucose tolerance and prehypertension [5], contraction of renal artery smooth muscle could contribute to diuretic resistance, which can be reflected by a higher loop-diuretic dosage. Thus, the dosage of loop diuretic might be a proxy for metabolic disorder severity rather than heart failure severity. The higher proportion of patients with atrial flutter/fibrillation, chronic obstructive pulmonary disease and renal disease in the higher diuretic dosage groups shown in Table 1 of the paper by Demant et al [1] not only frequently coexists with more severe heart failure, but also closely associates with more serious metabolic syndrome [6, 7]. Thus, it is not clear whether more severe heart failure or more severe metabolic syndrome underlies the increased risk of diabetes in the patients receiving the higher diuretic dosage. In conclusion, further investigations are urgently needed to assess the independent effect of heart failure on the risk of diabetes development.
References
Demant MN, Gislason GH, Køber L, Vaag A, Torp-Pedersen C, Andersson C (2014) Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study. Diabetologia. doi:10.1007/s00125-014-3259-z
Chan JN, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140
Cassis LA, Police SB, Yiannikouris F, Thatcher SE (2008) Local adipose tissue renin–angiotensin system. Curr Hypertens Rep 10:93–98
Marcus Y, Shefer G, Stern N (2013) Adipose tissue renin–angiotensin–aldosterone system (RAAS) and progression of insulin resistance. Mol Cell Endocrinol 378:1–14
Inaba S, Iwai M, Horiuchi M (2008) Role of RAS in prehypertension. Nihon Rinsho 66:1503–1508 [article in Japanese]
Watanabe H, Tanabe N, Watanabe T et al (2008) Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 117:1255–1260
Clini E, Crisafulli E, Radaeli A, Malerba M (2013) COPD and the metabolic syndrome: an intriguing association. Intern Emerg Med 8:283–289
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
Contribution statement
Both HBT and CM contributed to the conception, drafting and final approval of the version to be published.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, BT., Chen, M. Severity of heart failure and risk of incident diabetes: a reverse causation?. Diabetologia 57, 2000 (2014). https://doi.org/10.1007/s00125-014-3324-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-014-3324-7